Related Experiment Video
Updated: Apr 16, 2026

Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration
Published on: May 19, 2016
PAK1 regulates RUFY3-mediated gastric cancer cell migration and invasion
1Department of Cell Biology, Key Laboratory of Cell Biology, Ministry of Public Health and Key Laboratory of Medical Cell Biology, Ministry of Education, China Medical University, Shenyang 110001, China.
Abstract:
Actin protrusion at the cell periphery is central to the formation of invadopodia during tumor cell migration and invasion. Although RUFY3 (RUN and FYVE domain containing 3)/SINGAR1 (single axon-related1)/RIPX (Rap2 interacting protein X) has an important role in neuronal development, its pathophysiologic role and relevance to cancer are still largely unknown. The purpose of this study was to elucidate the molecular mechanisms by which RUFY3 involves in gastric cancer cell migration and invasion. Here, our data show that overexpression of RUFY3 leads to the formation of F-actin-enriched protrusive structures at the cell periphery and induces gastric cancer cell migration. Furthermore, P21-activated kinase-1 (PAK1) interacts with RUFY3, and promotes RUFY3 expression and RUFY3-induced gastric cancer cell migration; inhibition of PAK1 attenuates RUFY3-induced SGC-7901 cell migration and invasion. Importantly, we found that the inhibitory effect of cell migration and invasion is significantly enhanced by knockdown of both PAK1 and RUFY3 compared with knockdown of RUFY3 alone or PAK1 alone. Strikingly, we found significant upregulation of RUFY3 in gastric cancer samples with invasive carcinoma at pathologic TNM III and TNM IV stages, compared with their non-tumor counterparts. Moreover, an obvious positive correlation was observed between the protein expression of RUFY3 and PAK1 in 40 pairs of gastric cancer samples. Therefore, these findings provide important evidence that PAK1 can positively regulate RUFY3 expression, which contribute to the metastatic potential of gastric cancer cells, maybe blocking PAK1-RUFY3 signaling would become a potential metastasis therapeutic strategy for gastric cancer.
Insights
RUN and FYVE domain containing 3 (RUFY3) promotes gastric cancer cell migration and invasion. P21-activated kinase-1 (PAK1) upregulates RUFY3, suggesting PAK1-RUFY3 signaling as a potential therapeutic target for gastric cancer metastasis.
Area of Science:
- Oncology
- Cell Biology
- Molecular Mechanisms
Background:
- Actin protrusion drives tumor cell migration and invasion.
- The role of RUFY3 (RUN and FYVE domain containing 3) in cancer is largely unknown.
- RUFY3 is implicated in neuronal development.
Purpose of the Study:
- To investigate RUFY3's role in gastric cancer cell migration and invasion.
- To elucidate the molecular mechanisms underlying RUFY3's function in gastric cancer.
Main Methods:
- Overexpression and knockdown of RUFY3 and PAK1 (P21-activated kinase-1).
- Assessment of F-actin structures, cell migration, and invasion assays.
- Analysis of RUFY3 and PAK1 expression in gastric cancer tissues.
Main Results:
- RUFY3 overexpression induced F-actin protrusions and enhanced gastric cancer cell migration.
- PAK1 interacts with RUFY3, promoting its expression and RUFY3-driven migration.
- Combined knockdown of PAK1 and RUFY3 showed enhanced inhibition of migration and invasion.
- RUFY3 was upregulated in advanced gastric cancer stages (TNM III/IV) and correlated with PAK1 expression.
Conclusions:
- PAK1 positively regulates RUFY3 expression, contributing to gastric cancer cell metastasis.
- The PAK1-RUFY3 signaling pathway is crucial for gastric cancer cell invasion.
- Targeting the PAK1-RUFY3 pathway may offer a novel therapeutic strategy for gastric cancer metastasis.
Related Concept Videos
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Cancer Cell Migration through Invadopodia
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cell Polarization by Rho Proteins
Negative Regulator Molecules

